Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,444.00    14.00 (0.32%)
Bid:
4,442.00
Ask:
4,448.00
Spread: 6.00 (0.135%)
Market Cap: £2.07b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Muse Developments appointed preferred bidder

7 May 2013 09:00

RNS Number : 0362E
Morgan Sindall Group PLC
07 May 2013
 



7 May 2013

MORGAN SINDALL GROUP PLC

Muse Developments appointed preferred bidder for redevelopment of St Nicholas House,

former Aberdeen City Council HQ

Morgan Sindall Group plc announces that Muse Developments, its Urban Regeneration division, in joint venture with Aviva Investors, has been appointed as preferred bidder to work with Aberdeen City Council on the redevelopment of the St Nicholas House site in Aberdeen. The project will be fully funded by Aviva Investors, and has an overall value in excess of £100m.

Muse Developments proposes to develop a vibrant new mixed-use quarter for the city on the brownfield site which previously housed the local authority's corporate headquarters. The proposal is for a development which will house offices, a boutique hotel, cafés, restaurants and retail space, as well as creating a significant amount of public space including a small civic square and pedestrianising Broad Street. Provost Skene's House is also included in the proposals.

The Council will lease the development from Muse and receive a proportion of the rental profits for 35 years, after which the site and development will transfer into council ownership.

A public consultation lasting 12 weeks will be carried out before any planning application is submitted. The site will be developed in a single phase and Muse aims for completion during 2016.

John Morgan, Chief Executive of Morgan Sindall Group, commented: "Muse Developments is delighted with the opportunity of working on this scheme. We have a strong track record in similar joint venture regeneration projects and are confident that we will deliver a successful living and working destination. We are excited to be working with Aberdeen City Council and look forward to bringing innovation and long-term value for the people of Aberdeen."

ENDS

Editor's notes: 

Morgan Sindall Group plc

Morgan Sindall Group plc is a leading UK construction and regeneration group with a turnover of £2 billion, employing around 6,500 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, fit out, affordable housing, urban regeneration and investments.

Muse Developments

Muse Developments is one of the country's leading names in commercial development and urban regeneration. A national developer - with regional operations in Manchester, London, Leeds and Glasgow. It delivers complex mixed-use schemes - with the accent on quality and sustainability - and creates vibrant new places in towns and cities. Founded on the extensive experience of its management and delivery teams, Muse is driven by a desire to bring a fresh and innovative approach to property development. Muse is part of Morgan Sindall Group plc, a leading UK construction and regeneration group with revenue of over £2 billion and which operates through five divisions of construction and infrastructure, affordable housing, fit out, urban regeneration and investments.

 

ENQUIRIES:

 

Morgan Sindall Group plc Tel: 020 7307 9200

John Morgan, Chief Executive

Steve Crummett, Finance Director

 

 

 

Brunswick Tel: 0207 404 5959

Nina Coad

Alison Kay

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRANKNDBABKDAPK
Date   Source Headline
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights
2nd Jun 202511:14 amRNSCompany Secretary Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.